Analysis of pro- and antioxidant activity in the blood of women with different phenotypes of polycystic ovary syndrome and infertility

Darenskaya M.A., Kolesnikov S.I., Grebenkina L.A., Danusevich I.N., Lazareva L.M., Nadelyaeva Ya.G., Darzhaev Z.Yu., Nikitina O.A., Bazarova T.A., Kolesnikova L.I.

1Research Center of Family Health and Human Reproduction Problems, Irkutsk 664003, Timiryazeva str. 16, Russia 2Republican Perinatal Center, Ulan-Ude 670031, Solnechnaya str. 4A, Buryatia Republic, Russia
Objective. To reveal the specific features of the process of lipid peroxidation in reproductive-aged women with different phenotypes of polycystic ovary syndrome (PCOS).
Subjects and methods. Forty-eight reproductive-aged women with PCOS and infertility were examined and divided into 2 subgroups according to the availability of criteria: 1) classical phenotypes; 2) non-classical phenotypes. Infertile women without PCOS (n = 31) and healthy women (n = 28) were used as comparison groups.
Results. There were statistically significant differences in the examined parameters between the patients with different phenotypes of PCOS. At the same time, in the phenotype subgroups versus the controls and the infertile women without PCOS, the changes were mainly compensatory: slightly decreased superoxide dismutase activity and α-tocopherol concentrations and elevated retinol levels in the classical phenotype group and reduced levels of end thiobarbituric acid-reacting products of lipid peroxidation, increased α-tocopherol concentrations, and lower glutathione levels in the non-classical phenotype subgroup.
Conclusion. In general, in PCOS, and in its classic hyperandrogenic phenotypes in particular, the changes in the lipid peroxidation processes are adaptive in nature, which allows one to recommend a personalized approach to combination treatment of this category of patients.

Keywords

polycystic ovary syndrome
phenotypes
lipid peroxidation
antioxidants

Supplementary Materials

  1. Table. The content of pro and antioxidant status components patients with different phenotypes of polycystic ovary syndrome (M ± σ, Me, 25 - 75%)

References

1. Lizneva D., Suturina L., Walker W., Brakta S., Gavrilova-Jordan L., Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 2016; 106(1): 6-15.

2. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W. et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 2009; 91(2): 456-88.

3. Moran C., Arriaga M., Rodriguez G., Moran S. Obesity differentially affects phenotypes of polycystic ovary syndrome. Int. J. Endocrinol. 2012; 2012: 317241.

4. Yildiz B.O., Bozdag G., Yapici Z., Esinler I., Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 2012; 27(10): 3067-73.

5. Azziz R., Dumesic D., Goodarzi M. Polycystic ovary syndrome: an ancient disorder? Fertil. Steril. 2011; 95(5): 1544-8.

6. Mohamed-Hussein Z.A., Harun S. Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data. Theor. Biol. Med. Model. 2009;6: 18-31.

7. Pasquali R., Stener-Victorin E., Yildiz B., Duleba A., Hoeger K., Mason H. et al. PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin. Endocrinol. (Oxford). 2011; 74(4): 424-33.

8. Tarlatzis B., Fauser B., Legro R., Hoeger N., Pasquali R., Franks S. et al. Consensus on infertility treatment related to polycystic ovary syndrome. Hum. Reprod. 2008; 23(3): 462-77.

9. Колесникова Л.И., Сутурина Л.В., Лабыгина A.B., Лещенко О.Я., Федоров Б.А., Шолохов Л.Ф., Сафроненко A.B., Лебедева Л.Н., Кузьменко Е.Т., Лазарева Л.М., Наделяева Я.Г. Нарушения репродуктивого здоровья и репродуктивного потенциала в современных условиях Восточной Сибири. Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук. 2007; 2: 41-3. [Kolesnikova L.I., Suturina L.V., Labygina A.B. Leshhenko O.Ja., Fedorov B.A., Sholohov L.F., Safronenko A.B., Lebedeva L.N., Kuz’menko E.T., Lazareva L.M., Nadeljaeva Ja.G. Disorders of reproductive health and reproductive potential in modern conditions of Eastern Siberia. Bjulleten’ VSNC SO RAMN. 2007; 2: 41-43. (in Russian)]

10. Gonzаlez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012; 77(4): 300-5.

11. Уварова В.Н., Хащенко Е.П. Синдром поликистозных яичников с позиции современных данных патогенеза. Репродуктивное здоровье детей и подростков. 2013; 5: 54-60. [Uvarova V.N., Hashhenko E.P. Polycystic Ovary Syndrome from the perspective of modern pathogenesis of data. Reproduktivnoe zdorovye detej i podrostkov. 2013; 5: 54-60. (in Russian)]

12. Kolesnikova L.I., Darenskaya М.А., Grebenkina L.A., Labygina A.V., Suturina L.V., Dolgikh M.I., Shiphineeva T.I., Darzhaev Z.Yu., Tsyrenov T.B., Rinchindorzhieva M.P. Activity of lipid peroxidation in infertile women from different populations. Bull. Exp. Biol. Med. 2012; 154(2): 203-5.

13. Murri M., Luque-Ramírez M., Insenser M., Ojeda-Ojeda M., Escobar-Morreale H.F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum. Reprod. Update. 2013; 19(3): 268-88.

14. Duleba A.J., Dokras A. Is PCOS an inflammatory process? Fertil. Steril. 2012; 97(1): 7-12.

15. Aponte A., Agarwal A. Oxidative stress impact on the fertility of women with polycystic ovary syndrome. In: Agarwal A., Aziz N., Rizk B., eds. Studies on women’s health. Humana Press; 2012: 169-80.

16. Меньщикова Е.Б., Зенков Н.К., Ланкин В.З., Бондарь И.А., Труфакин В.А. Окислительный стресс: патологические состояния и заболевания. Новосибирск: Арта; 2008. [Menshhikova E.B., Zenkov N.K., Lankin V.Z., Bondar’ I.A., Trufakin V.A. Oxidative stress: pathological conditions and diseases. Novosibirsk: Arta, 2008; 284 s. (in Russian)]

17. Ших Е.В., Махова А.А. Роль аскорбиновой кислоты и токоферола в профилактике и лечении заболеваний с точки зрения доказательной медицины. Терапевтический архив. 2015; 87(4): 98-102. [Shih E.V., Mahova A.A. Role of ascorbic acid and tocopherol in the prevention and treatment of diseases from the perspective of evidence-based medicine. Terapevticheskij arhiv. 2015; 87(4): 98-102. (in Russian)]

18. Сутурина Л.В., Попова Л.Н. Динамика клинических симптомов и коррекция антиоксидантной недостаточности у женщин с диффузной мастопатией при использовании растительного препарата мастодинон. Акушерство и гинекология. 2012; 8-1: 56-9. [Suturina L.V., Popova L.N. The time course of changes in the clinical symptoms of antioxidandt deficiency and its correction with the herbal agent mastodynon in women with diffuse mastopathy. Akusherstvo i ginekologija/Obstetrics and Gynecology. 2012; (8-1): 56-9. (in Russian)]

19. Кузнецова И.В. Роль окислительного стресса и антиоксидантной защиты в репродукции человека. Акушерство и гинекология. 2016; 3: 116-21. http://dx.doi.org/10.18565/aig.2016.3.116-121 [Kuznetsova I.V. Role of oxidative stress and antioxidant defense in human reproduction. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2016; (3): 116-21. (in Russian) http://dx.doi.org/10.18565/aig.2016.3.116-121]

20. Колесникова Л.И., Гребенкина Л.А., Даренская М.А., Власов Б.Я. Окислительный стресс как неспецифическое патогенетическое звено репродуктивных нарушений (Обзор). Бюллетень Сибирского отделения Российской академии медицинских наук. 2012; 32(1): 58-66. [Kolesnikova L.I., Grebenkina L.A., Darenskaja M.A., Vlasov B.Ja. Oxidative stress as a nonspecific pathogenetic link of reproductive disorders (Review). Bjulleten’ SO RAMN. 2012; 32(1): 58-66. (in Russian)]

21. Morin-Papunen C.L., Duleba A.J., Bloigu A., Järvelin M., Saikku P., Pouta A. Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: A new etiologic factor in polycystic ovary syndrome? Fertil. Steril. 2010; 94(5): 1799-804.

Received 27.10.2016

Accepted 11.11.2016

About the Authors

Darenskaya Marina Alexandrovna, doctor of biological sciences, leading researcher of the laboratory of pathophysiology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: marina_darenskaya@inbox.ru
Kolesnikov Sergei Ivanovich, Academician of the Russian Academy of Sciences, leading researcher, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru.
Grebenkina Lyudmila Anatoljevna, doctor of biological sciences, leading researcher of the laboratory of pathophysiology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Danusevich Irina Nikolaevna, doctor of medical sciences, senior researcher of the laboratory of gynecological endocrinology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Lazareva Lyudmila, candidate of medical sciences, senior researcher of the laboratory of gynecological endocrinology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Nadelyaeva Yana Gennadjevna, candidate of medical sciences, researcher of the laboratory of gynecological endocrinology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Darzhaev Zorikto Yurjevich, candidate of medical sciences, head of Human planning and reproduction center, Republican Perinatal Center.
670031, Buryatia Republic, Ulan-Ude, Solnechnaya str. 4A. E-mail: iphr@sbamsr.irk.ru
Nikitina Olga Andreevna, candidate of biological sciences, researcher of the laboratory of pathophysiology, Research Center of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Bazarova Tatiana Alexandrovna, researcher of the laboratory of gynecological endocrinology, Research Center of Family Health and Human Reproduction Problems.
664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru
Kolesnikova Lubov Iljinichna, member of Russian Academy of Sciences, professor, doctor of medical sciences, scientific director, Research Center
of Family Health and Human Reproduction Problems. 664003, Russia, Irkutsk, Timiryazeva str. 16. Tel.: +73952207636. E-mail: iphr@sbamsr.irk.ru

For citations: Darenskaya M.A., Kolesnikov S.I., Grebenkina L.A.,
Danusevich I.N., Lazareva L.M., Nadelyaeva Ya.G., Darzhaev Z.Yu., Nikitina O.A.,
Bazarova T.A., Kolesnikova L.I. Analysis of pro- and antioxidant activity in the blood
of women with different phenotypes of polycystic ovary syndrome and infertility.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (8): 86-91. (in Russian)
http://dx.doi.org/10.18565/aig.2017.8.86-91

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.